Fed. Circ. To Review Inequitable Conduct Standards

Law360, New York (April 26, 2010, 4:44 PM EDT) -- In a potentially tectonic move, the U.S. Court of Appeals for the Federal Circuit has agreed to clarify the doctrine of inequitable conduct, granting an en banc rehearing to Abbott Laboratories in patent infringement litigation against Becton Dickinson & Co. and Bayer Healthcare LLC over blood glucose test strips.

On Monday, the Federal Circuit vacated a January decision by an appeals court panel and granted the rehearing to Abbott, which contends that the panel wrongly upheld an inequitable conduct ruling, rendering the company's patent covering disposable...
To view the full article, register now.